Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing

Prior studies have suggested that natural killer (NK) cell function might be impaired in chronic hepatitis C virus (HCV) infection. Circulating NK cell frequency and cytolytic activity were examined freshly ex vivo in HCV-infected and uninfected subjects. Surprisingly, the intrinsic cytolytic activi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Md.), 2006-03, Vol.43 (3), p.573-580
Hauptverfasser: MORISHIMA, Chihiro, PASCHAL, Denise M, WANG, Chia C, YOSHIHARA, Christina S, WOOD, Brent L, YEO, Anthony E. T, EMERSON, Scott S, SHUHART, Margaret C, GRETCH, David R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 580
container_issue 3
container_start_page 573
container_title Hepatology (Baltimore, Md.)
container_volume 43
creator MORISHIMA, Chihiro
PASCHAL, Denise M
WANG, Chia C
YOSHIHARA, Christina S
WOOD, Brent L
YEO, Anthony E. T
EMERSON, Scott S
SHUHART, Margaret C
GRETCH, David R
description Prior studies have suggested that natural killer (NK) cell function might be impaired in chronic hepatitis C virus (HCV) infection. Circulating NK cell frequency and cytolytic activity were examined freshly ex vivo in HCV-infected and uninfected subjects. Surprisingly, the intrinsic cytolytic activity of peripheral blood NK-enriched cells was similar between HCV-infected and uninfected groups (P = .91). Although the percentage of circulating CD3- CD16/56+ NK cells was 30% lower in HCV-infected compared with uninfected subjects (P = .02) paralleled by a decrease of CD56(dim) cytolytic NK cells (P = .02), overall K562 cytolysis by unfractionated peripheral blood mononuclear cells was not affected (P = .29). Analysis of the relationships between NK cytolytic activity and other clinical information revealed an inverse association with liver fibrosis stage (P = .035). In conclusion, NK cell cytolytic function does not appear to be impaired in chronic hepatitis C, but higher levels of NK cell cytolysis are associated with less liver fibrosis.
doi_str_mv 10.1002/hep.21073
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67824891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67824891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c273t-a952af1139e03975a86b0b66d37f1bb4db68676c84a4d7646780d72d243ad7383</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EoqWw4AeQNyCxSPEjsZMlKk9RwQZ2SJHjBzWkcbHdivw9LkTqajZn7tw5AJxiNMUIkauFXk0JRpzugTEuCM8oLdA-GCPCUVZhWo3AUQifCKEqJ-UhGGGWV4wSPgbvN1p6LYJW8PkJSt220Hj9vdad7KHtoFx411kJ0wkRbbQBzqByOsDORSiM0TJC_QM3duOg7KNr-5joL9u2tvs4BgdGtEGfDHMC3u5uX2cP2fzl_nF2Pc8k4TRmoiqIMDj11IhWvBAla1DDmKLc4KbJVcNKxpksc5ErznLGS6Q4USSnQnFa0gm4-M9deZeqh1gvbdj-Ijrt1qFOCyQvk4gJuPwHpXcheG3qlbdL4fsao3qrsk5_1n8qE3s2hK6bpVY7cnCXgPMBEEGK1njRSRt2HC-qAqWkX4VMewI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67824891</pqid></control><display><type>article</type><title>Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>MORISHIMA, Chihiro ; PASCHAL, Denise M ; WANG, Chia C ; YOSHIHARA, Christina S ; WOOD, Brent L ; YEO, Anthony E. T ; EMERSON, Scott S ; SHUHART, Margaret C ; GRETCH, David R</creator><creatorcontrib>MORISHIMA, Chihiro ; PASCHAL, Denise M ; WANG, Chia C ; YOSHIHARA, Christina S ; WOOD, Brent L ; YEO, Anthony E. T ; EMERSON, Scott S ; SHUHART, Margaret C ; GRETCH, David R</creatorcontrib><description>Prior studies have suggested that natural killer (NK) cell function might be impaired in chronic hepatitis C virus (HCV) infection. Circulating NK cell frequency and cytolytic activity were examined freshly ex vivo in HCV-infected and uninfected subjects. Surprisingly, the intrinsic cytolytic activity of peripheral blood NK-enriched cells was similar between HCV-infected and uninfected groups (P = .91). Although the percentage of circulating CD3- CD16/56+ NK cells was 30% lower in HCV-infected compared with uninfected subjects (P = .02) paralleled by a decrease of CD56(dim) cytolytic NK cells (P = .02), overall K562 cytolysis by unfractionated peripheral blood mononuclear cells was not affected (P = .29). Analysis of the relationships between NK cytolytic activity and other clinical information revealed an inverse association with liver fibrosis stage (P = .035). In conclusion, NK cell cytolytic function does not appear to be impaired in chronic hepatitis C, but higher levels of NK cell cytolysis are associated with less liver fibrosis.</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.21073</identifier><identifier>PMID: 16496327</identifier><identifier>CODEN: HPTLD9</identifier><language>eng</language><publisher>Hoboken, NJ: Wiley</publisher><subject>Adult ; Biological and medical sciences ; Cytotoxicity, Immunologic - immunology ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatitis C, Chronic - immunology ; Human viral diseases ; Humans ; Infectious diseases ; Killer Cells, Natural - immunology ; Liver Cirrhosis - immunology ; Lymphocyte Count ; Lymphocyte Subsets - immunology ; Male ; Medical sciences ; Viral diseases ; Viral hepatitis</subject><ispartof>Hepatology (Baltimore, Md.), 2006-03, Vol.43 (3), p.573-580</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c273t-a952af1139e03975a86b0b66d37f1bb4db68676c84a4d7646780d72d243ad7383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17595007$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16496327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MORISHIMA, Chihiro</creatorcontrib><creatorcontrib>PASCHAL, Denise M</creatorcontrib><creatorcontrib>WANG, Chia C</creatorcontrib><creatorcontrib>YOSHIHARA, Christina S</creatorcontrib><creatorcontrib>WOOD, Brent L</creatorcontrib><creatorcontrib>YEO, Anthony E. T</creatorcontrib><creatorcontrib>EMERSON, Scott S</creatorcontrib><creatorcontrib>SHUHART, Margaret C</creatorcontrib><creatorcontrib>GRETCH, David R</creatorcontrib><title>Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>Prior studies have suggested that natural killer (NK) cell function might be impaired in chronic hepatitis C virus (HCV) infection. Circulating NK cell frequency and cytolytic activity were examined freshly ex vivo in HCV-infected and uninfected subjects. Surprisingly, the intrinsic cytolytic activity of peripheral blood NK-enriched cells was similar between HCV-infected and uninfected groups (P = .91). Although the percentage of circulating CD3- CD16/56+ NK cells was 30% lower in HCV-infected compared with uninfected subjects (P = .02) paralleled by a decrease of CD56(dim) cytolytic NK cells (P = .02), overall K562 cytolysis by unfractionated peripheral blood mononuclear cells was not affected (P = .29). Analysis of the relationships between NK cytolytic activity and other clinical information revealed an inverse association with liver fibrosis stage (P = .035). In conclusion, NK cell cytolytic function does not appear to be impaired in chronic hepatitis C, but higher levels of NK cell cytolysis are associated with less liver fibrosis.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cytotoxicity, Immunologic - immunology</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatitis C, Chronic - immunology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Killer Cells, Natural - immunology</subject><subject>Liver Cirrhosis - immunology</subject><subject>Lymphocyte Count</subject><subject>Lymphocyte Subsets - immunology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtOwzAQRS0EoqWw4AeQNyCxSPEjsZMlKk9RwQZ2SJHjBzWkcbHdivw9LkTqajZn7tw5AJxiNMUIkauFXk0JRpzugTEuCM8oLdA-GCPCUVZhWo3AUQifCKEqJ-UhGGGWV4wSPgbvN1p6LYJW8PkJSt220Hj9vdad7KHtoFx411kJ0wkRbbQBzqByOsDORSiM0TJC_QM3duOg7KNr-5joL9u2tvs4BgdGtEGfDHMC3u5uX2cP2fzl_nF2Pc8k4TRmoiqIMDj11IhWvBAla1DDmKLc4KbJVcNKxpksc5ErznLGS6Q4USSnQnFa0gm4-M9deZeqh1gvbdj-Ijrt1qFOCyQvk4gJuPwHpXcheG3qlbdL4fsao3qrsk5_1n8qE3s2hK6bpVY7cnCXgPMBEEGK1njRSRt2HC-qAqWkX4VMewI</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>MORISHIMA, Chihiro</creator><creator>PASCHAL, Denise M</creator><creator>WANG, Chia C</creator><creator>YOSHIHARA, Christina S</creator><creator>WOOD, Brent L</creator><creator>YEO, Anthony E. T</creator><creator>EMERSON, Scott S</creator><creator>SHUHART, Margaret C</creator><creator>GRETCH, David R</creator><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing</title><author>MORISHIMA, Chihiro ; PASCHAL, Denise M ; WANG, Chia C ; YOSHIHARA, Christina S ; WOOD, Brent L ; YEO, Anthony E. T ; EMERSON, Scott S ; SHUHART, Margaret C ; GRETCH, David R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c273t-a952af1139e03975a86b0b66d37f1bb4db68676c84a4d7646780d72d243ad7383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cytotoxicity, Immunologic - immunology</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatitis C, Chronic - immunology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Killer Cells, Natural - immunology</topic><topic>Liver Cirrhosis - immunology</topic><topic>Lymphocyte Count</topic><topic>Lymphocyte Subsets - immunology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MORISHIMA, Chihiro</creatorcontrib><creatorcontrib>PASCHAL, Denise M</creatorcontrib><creatorcontrib>WANG, Chia C</creatorcontrib><creatorcontrib>YOSHIHARA, Christina S</creatorcontrib><creatorcontrib>WOOD, Brent L</creatorcontrib><creatorcontrib>YEO, Anthony E. T</creatorcontrib><creatorcontrib>EMERSON, Scott S</creatorcontrib><creatorcontrib>SHUHART, Margaret C</creatorcontrib><creatorcontrib>GRETCH, David R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MORISHIMA, Chihiro</au><au>PASCHAL, Denise M</au><au>WANG, Chia C</au><au>YOSHIHARA, Christina S</au><au>WOOD, Brent L</au><au>YEO, Anthony E. T</au><au>EMERSON, Scott S</au><au>SHUHART, Margaret C</au><au>GRETCH, David R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>43</volume><issue>3</issue><spage>573</spage><epage>580</epage><pages>573-580</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><coden>HPTLD9</coden><abstract>Prior studies have suggested that natural killer (NK) cell function might be impaired in chronic hepatitis C virus (HCV) infection. Circulating NK cell frequency and cytolytic activity were examined freshly ex vivo in HCV-infected and uninfected subjects. Surprisingly, the intrinsic cytolytic activity of peripheral blood NK-enriched cells was similar between HCV-infected and uninfected groups (P = .91). Although the percentage of circulating CD3- CD16/56+ NK cells was 30% lower in HCV-infected compared with uninfected subjects (P = .02) paralleled by a decrease of CD56(dim) cytolytic NK cells (P = .02), overall K562 cytolysis by unfractionated peripheral blood mononuclear cells was not affected (P = .29). Analysis of the relationships between NK cytolytic activity and other clinical information revealed an inverse association with liver fibrosis stage (P = .035). In conclusion, NK cell cytolytic function does not appear to be impaired in chronic hepatitis C, but higher levels of NK cell cytolysis are associated with less liver fibrosis.</abstract><cop>Hoboken, NJ</cop><pub>Wiley</pub><pmid>16496327</pmid><doi>10.1002/hep.21073</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0270-9139
ispartof Hepatology (Baltimore, Md.), 2006-03, Vol.43 (3), p.573-580
issn 0270-9139
1527-3350
language eng
recordid cdi_proquest_miscellaneous_67824891
source MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals
subjects Adult
Biological and medical sciences
Cytotoxicity, Immunologic - immunology
Female
Gastroenterology. Liver. Pancreas. Abdomen
Hepatitis C, Chronic - immunology
Human viral diseases
Humans
Infectious diseases
Killer Cells, Natural - immunology
Liver Cirrhosis - immunology
Lymphocyte Count
Lymphocyte Subsets - immunology
Male
Medical sciences
Viral diseases
Viral hepatitis
title Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A26%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20NK%20cell%20frequency%20in%20chronic%20hepatitis%20C%20does%20not%20affect%20ex%20vivo%20cytolytic%20killing&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=MORISHIMA,%20Chihiro&rft.date=2006-03-01&rft.volume=43&rft.issue=3&rft.spage=573&rft.epage=580&rft.pages=573-580&rft.issn=0270-9139&rft.eissn=1527-3350&rft.coden=HPTLD9&rft_id=info:doi/10.1002/hep.21073&rft_dat=%3Cproquest_cross%3E67824891%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67824891&rft_id=info:pmid/16496327&rfr_iscdi=true